Japan Develops Small Metric Screw Screeners and Solar Panel Screws

Japan Develops Small Metric Screw Screeners and Solar Panel Screws The "AcculateImage System" (patent pending) screening machine developed by Japan Fujisei Co., Ltd. will save a lot of complicated settings. It can inspect the M4 to M8 metric screws in various shapes. The biggest feature is that no matter whether it is a novice, a concurrent person or an elderly person. People can easily make settings, thanks to the machine's introduction of the industry's newest dialog-style operation (more user-friendly interface panel, easy to use).

Tokyo Screws Manufacturing Co., Ltd. Adds M8 and M10 Screws to Solar Panels Production and sales of the Tokyo Screws Co., Ltd. has promoted the development of its D-Lock fasteners (specially designed for fastening channels) to the solar panel field. In addition to increasing the M8 and M10 specifications, anti-corrosion fasteners have also been added to the field of corrosion zinc-tin alloy coatings.

Empagliflozin API

Empagliflozin is an orally available competitive inhibitor of sodium-glucose co-transporter 2 (SGLT2; SLC5A2) with antihyperglycemic activity. Upon oral administration, empagliflozin selectively and potently inhibits SGLT2 in the kidneys, thereby suppressing the reabsorption of glucose in the proximal tubule. Inhibition of SGLT2 increases urinary glucose excretion by the kidneys, resulting in a reduction of plasma glucose levels in an insulin-independent manner. SGLT2, a transport protein exclusively expressed in the proximal renal tubules, mediates approximately 90% of renal glucose reabsorption from tubular fluid.

Empagliflozin is a C-glycosyl compound consisting of a beta-glucosyl residue having a (4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl group at the anomeric centre. A sodium-glucose co-transporter 2 inhibitor used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It has a role as a sodium-glucose transport protein subtype 2 inhibitor and a hypoglycemic agent. It is a C-glycosyl compound, an aromatic ether, a tetrahydrofuryl ether and a member of monochlorobenzenes.

Empagliflozin; 864070-44-0; JARDIANCE; BI 10773; Empagliflozin (BI 10773);

 Shandong Haohong Biotechnology Co., Ltd. , https://www.haohongpharma.com